Enovis (ENOV) Other Operating Expenses (2022)

Enovis' (ENOV) quarterly Other Operating Expenses came in at $4.6 million in Q4 2022, up 571.79% on a QoQ basis from -$975000.0 in Q3 2022.

Enovis (ENOV) Other Operating Expenses (2022) Analysis & Trends

Enovis (ENOV) has 1 years of Other Operating Expenses data on file, last reported at $4.6 million in Q4 2022.

On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $4.6 million in Q4 2022; TTM through Sep 2023 was $4.6 million, a 85.65% decrease from a year earlier, with the FY2022 full-year figure at $36.7 million, changed N/A from the prior year.
Other Operating Expenses for Q4 2022 stood at $4.6 million, up from -$975000.0 in the prior quarter.
Over the last five years, Other Operating Expenses for ENOV reached as high as $33.0 million in Q3 2022 and fell as low as -$975000.0 in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Enovis	1.50 Bn	1.47 Bn	365.49 Mn

Download Data